Abstract
Purpose
Canada has the highest rate of multiple sclerosis (MS) in the world. Sleep disturbance in individuals with MS is approximately four times higher than in the general population. This is concerning given that poor sleep quality negatively affects one’s mental and physical well-being. The objectives of this study are (1) to document the prevalence of sleep problems in a Canadian sample of older individuals living with MS, (2) to identify demographic and clinical factors associated with poor sleep, and (3) to investigate the potential impact of possible sleep-promoting and sleep-interfering medications.
Method
This study is a secondary analysis of sleep and related variables from the Canadian survey of health, lifestyle, and aging with multiple sclerosis study. The survey consists of 743 Canadians 55 years or older with a diagnosis of MS. We asked participants, “In the past 2 weeks, how much have you been bothered by problems sleeping?”
Results
Overall, 43% of patients with MS reported problems sleeping. The strongest associations were found between poor sleep and number of comorbidities, clinically significant anxiety, and a greater perceived impact of physical symptoms of MS on functioning.
Conclusion
Sleep problems are prevalent in individuals with MS. Individuals who had clinically significant levels of anxiety were roughly two times more likely to have trouble sleeping when compared to individuals without anxiety. Efforts should focus on early identification and effective interventions for poor sleep in individuals living with MS.
Similar content being viewed by others
References
Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502–17.
World Health Organization. Atlas multiple sclerosis resources in the world 2008. Geneva: WHO Press; 2008.
Statistics Canada. Table 105-1300- neurological conditions, by age group and sex, household population aged 0 and over, 2010/2011. Available at: http://www5.statcan.gc.ca/cansim/a26?lang=eng&retrLang=eng&id=1051300&paSer=&pattern=&stByVal=1&p1=1&p2=31&tabMode=dataTable&csid. Accessed 10/13, 2015.
Renoux C. Natural history of multiple sclerosis: long-term prognostic factors. Neurol Clin. 2011;29(2):293–308.
Attarian H. Importance of sleep in the quality of life of multiple sclerosis patients: a long under-recognized issue. Sleep Med. 2009;10(1):7–8.
Brass SD, Li CS, Auerbach S. The underdiagnosis of sleep disorders in patients with multiple sclerosis. J Clin Sleep Med. 2014;10(9):1025–31.
Bamer AM, Johnson KL, Amtmann D, Kraft GH. Prevalence of sleep problems in individuals with multiple sclerosis. Mult Scler. 2008;14(8):1127–30.
Lobentanz IS, Asenbaum S, Vass K, Sauter C, Klosch G, Kollegger H, et al. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand. 2004;110(1):6–13.
Merlino G, Fratticci L, Lenchig C, Valente M, Cargnelutti D, Picello M, et al. Prevalence of ‘poor sleep’ among patients with multiple sclerosis: an independent predictor of mental and physical status. Sleep Med. 2009;10(1):26–34.
Boe Lunde HM, Aae TF, Indrevag W, Aarseth J, Bjorvatn B, Myhr KM, et al. Poor sleep in patients with multiple sclerosis. PLoS One. 2012;7(11):e49996.
Irwin MR. Why sleep is important for health: a psychoneuroimmunology perspective. Annu Rev Psychol. 2015;66:143–72.
Gallicchio L, Kalesan B. Sleep duration and mortality: a systematic review and meta-analysis. J Sleep Res. 2009;18(2):148–58.
Stanton BR, Barnes F, Silber E. Sleep and fatigue in multiple sclerosis. Mult Scler. 2006;12(4):481–6.
Kaynak H, Altintas A, Kaynak D, Uyanik O, Saip S, Agaoglu J, et al. Fatigue and sleep disturbance in multiple sclerosis. Eur J Neurol. 2006;13(12):1333–9.
Attarian HP, Brown KM, Duntley SP, Carter JD, Cross AH. The relationship of sleep disturbances and fatigue in multiple sclerosis. Arch Neurol. 2004;61(4):525–8.
Vitkova M, Gdovinova Z, Rosenberger J, Szilasiova J, Nagyova I, Mikula P, et al. Factors associated with poor sleep quality in patients with multiple sclerosis differ by disease duration. Disabil Health J. 2014;7(4):466–71.
Kaminska M, Kimoff RJ, Schwartzman K, Trojan DA. Sleep disorders and fatigue in multiple sclerosis: evidence for association and interaction. J Neurol Sci. 2011;302(1–2):7–13.
Nagaraj K, Taly AB, Gupta A, Prasad C, Christopher R. Depression and sleep disturbances in patients with multiple sclerosis and correlation with associated fatigue. J Neurosci Rural Pract. 2013;4(4):387–91.
Leineweber C, Kecklund G, Janszky I, Akerstedt T, Orth-Gomer K. Poor sleep increases the prospective risk for recurrent events in middle-aged women with coronary disease. The Stockholm Female Coronary Risk Study. J Psychosom Res. 2003;54(2):121–7.
Michal M, Wiltink J, Kirschner Y, Schneider A, Wild PS, Munzel T, et al. Complaints of sleep disturbances are associated with cardiovascular disease: results from the Gutenberg Health Study. PLoS One. 2014;9(8):e104324.
Rahe C, Czira ME, Teismann H, Berger K. Associations between poor sleep quality and different measures of obesity. Sleep Med. 2015;16(10):1225–8.
Knutson KL, Van Cauter E. Associations between sleep loss and increased risk of obesity and diabetes. Ann N Y Acad Sci. 2008;1129:287–304.
Ploughman M, Beaulieu S, Harris C, Hogan S, Manning OJ, Alderdice PW, et al. The Canadian survey of health, lifestyle and ageing with multiple sclerosis: methodology and initial results. BMJ Open. 2014;4(7):e005718. -2014-005718
Ploughman M, Austin MW, Murdoch M, Kearney A, Godwin M, Stefanelli M. The path to self-management: a qualitative study involving older people with multiple sclerosis. Physiother Can. 2012;64(1):6–17.
Ploughman M, Austin MW, Murdoch M, Kearney A, Fisk JD, Godwin M, et al. Factors influencing healthy aging with multiple sclerosis: a qualitative study. Disabil Rehabil. 2012;34(1):26–33.
Ploughman M, Austin M, Stefanelli M, Godwin M. Applying cognitive debriefing to pre-test patient-reported outcomes in older people with multiple sclerosis. Qual Life Res. 2010;19(4):483–7.
Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain. 2001;124(Pt 5):962–73.
Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61–5.
Yeo D, Faleiro R, Lincoln N. Barthel ADL Index: a comparison of administration methods. Clin Rehabil. 1995;9:34–9.
van der Putten JJ, Hobart JC, Freeman JA, Thompson AJ. Measuring change in disability after inpatient rehabilitation: comparison of the responsiveness of the Barthel Index and the Functional Independence Measure. J Neurol Neurosurg Psychiatry. 1999;66(4):480–4.
American College of Sports Medicine. ACSM’s guidelines for exercise testing and prescription. 8th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2010.
Ploughman M, Harris C, Wallack EM, Drodge O, Beaulieu S, Mayo N, et al. Predictors of exercise participation in ambulatory and non-ambulatory older people with multiple sclerosis. PeerJ. 2015;3:e1158.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.
Honarmand K, Feinstein A. Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Mult Scler. 2009;15(12):1518–24.
Wagnild GM, Young HM. Development and psychometric evaluation of the Resilience Scale. J Nurs Meas. 1993;1(2):165–78.
Long KA, Weinert C. Descriptions and perceptions of health among rural and urban adults with multiple sclerosis. Res Nurs Health. 1992;15(5):335–42.
Foley D, Ancoli-Israel S, Britz P, Walsh J. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res. 2004;56(5):497–502.
Ford ES, Cunningham TJ, Giles WH, Croft JB. Trends in insomnia and excessive daytime sleepiness among U.S. adults from 2002 to 2012. Sleep Med. 2015;16(3):372–8.
Fortier-Brochu E, Beaulieu-Bonneau S, Ivers H, Morin CM. Insomnia and daytime cognitive performance: a meta-analysis. Sleep Med Rev. 2012;16(1):83–94.
Daley M, Morin CM, LeBlanc M, Gregoire JP, Savard J, Baillargeon L. Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents. Sleep Med. 2009;10(4):427–38.
Garfield AC, Lincoln NB. Factors affecting anxiety in multiple sclerosis. Disabil Rehabil. 2012;34(24):2047–52.
Havlikova E, van Dijk JP, Nagyova I, Rosenberger J, Middel B, Dubayova T, et al. The impact of sleep and mood disorders on quality of life in Parkinson’s disease patients. J Neurol. 2011;258(12):2222–9.
Leblanc MF, Desjardins S, Desgagne A. Sleep problems in anxious and depressive older adults. Psychol Res Behav Manag. 2015;8:161–9.
Cote I, Trojan DA, Kaminska M, Cardoso M, Benedetti A, Weiss D, et al. Impact of sleep disorder treatment on fatigue in multiple sclerosis. Mult Scler. 2013;19(4):480–9.
Carey M, Jones KA, Yoong SL, D'Este C, Boyes AW, Paul C, et al. Comparison of a single self-assessment item with the PHQ-9 for detecting depression in general practice. Fam Pract 2014 15.
Yuan H, Hopkins M, Goldberg JD, Silberstein SD. Single-item migraine screening tests, self-reported bothersome headache or stripe pattern hypersensitivity? Acta Neurol Scand. 2016;134(4):277–83.
McNeely J, Cleland CM, Strauss SM, Palamar JJ, Rotrosen J, Saitz R. Validation of self-administered single-item screening questions (SISQs) for unhealthy alcohol and drug use in primary care patients. J Gen Intern Med. 2015;30(12):1757–64.
Burkhalter H, Wirz-Justice A, Cajochen C, Weaver T, Steiger J, Fehr T, et al. Validation of a single item to assess daytime sleepiness for the Swiss Transplant Cohort Study. Prog Transplant. 2013;23(3):220–8.
MacGregor KL, Funderburk JS, Pigeon W, Maisto SA. Evaluation of the PHQ-9 item 3 as a screen for sleep disturbance in primary care. J Gen Intern Med. 2012;27(3):339–44.
Acknowledgements
The study was supported by the MS Society of Canada and local chapters, provincial MS clinic neurologists, MS nurses, administrative and research staff, and the Rehabilitation and Continuing Care Program, Eastern Health Authority.
We thank the Health, Lifestyle and Aging with MS Canadian Consortium: Nancy Mayo, PhD; John D. Fisk, PhD; A. Dessa Sadovnick, PhD; Paul O’Connor, MD, FRCPC; Sarah A. Morrow, MD, FRCPC; Katherine B. Knox, MD, FRCPC; Luanne M. Metz, MD, FRCPC; Penelope Smyth, MD, FRCPC; Ruth Ann Marrie, MD, PhD; Serge Beaulieu; Chelsea Harris BKin, MPH; Penelope W. Alderdice, PhD; Mark Stefanelli, MD FRCPC; and Marshall Godwin, MD.
We specifically acknowledge the work of site coordinators: Chelsea Harris, Stephen Hogan, Olivia Manning, Olivia Drodge, Trudy Campbell, Heather Rosehart, Amy Cuthbertson, Darren Nickel, Pam Dumont, Madonna de Lemos, Deborah Goldberg, Irene Yee, Nicholas Hall, Maureen Perera, Sarah Williamson, Carolina Moriello, and Vanessa Bouchard.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Funding
This study was funded by a Canadian Institutes for Health Research (CIHR) post-doctoral fellowship (MP), Newfoundland and Labrador Applied Health Research Healthy Aging Project Grant, the Health Care Foundation Project Grant (Eastern Health Authority), and the Physiotherapy Foundation of Canada Alberta Research Award.
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Garland, S.N., Scurrey, S.R.M., Ploughman, M. et al. Factors Associated with Poor Sleep in Older Adults with Multiple Sclerosis. Int.J. Behav. Med. 24, 937–945 (2017). https://doi.org/10.1007/s12529-017-9653-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12529-017-9653-4